NO171639C - Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater

Info

Publication number
NO171639C
NO171639C NO893039A NO893039A NO171639C NO 171639 C NO171639 C NO 171639C NO 893039 A NO893039 A NO 893039A NO 893039 A NO893039 A NO 893039A NO 171639 C NO171639 C NO 171639C
Authority
NO
Norway
Prior art keywords
imidazolpyrazold
derivatives
preparation
therapeutic active
aralkyl
Prior art date
Application number
NO893039A
Other languages
English (en)
Norwegian (no)
Other versions
NO171639B (no
NO893039L (no
NO893039D0 (no
Inventor
Atsusuke Terada
Kazuyuki Wachi
Hachio Miyazawa
Yoshio Iizuka
Keiichi Tabata
Kazuo Hasegawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO893039D0 publication Critical patent/NO893039D0/no
Publication of NO893039L publication Critical patent/NO893039L/no
Publication of NO171639B publication Critical patent/NO171639B/no
Publication of NO171639C publication Critical patent/NO171639C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16BDEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B17/00Connecting constructional elements or machine parts by a part of or on one member entering a hole in the other and involving plastic deformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO893039A 1988-07-26 1989-07-26 Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater NO171639C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18613288 1988-07-26

Publications (4)

Publication Number Publication Date
NO893039D0 NO893039D0 (no) 1989-07-26
NO893039L NO893039L (no) 1990-01-29
NO171639B NO171639B (no) 1993-01-04
NO171639C true NO171639C (no) 1993-04-14

Family

ID=16182931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893039A NO171639C (no) 1988-07-26 1989-07-26 Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater

Country Status (14)

Country Link
EP (1) EP0353047B1 (fi)
JP (1) JPH0753730B2 (fi)
KR (1) KR940009785B1 (fi)
CN (2) CN1032207C (fi)
AT (1) ATE112569T1 (fi)
CA (1) CA1340444C (fi)
DE (1) DE68918651T2 (fi)
DK (1) DK369289A (fi)
ES (1) ES2065992T3 (fi)
FI (1) FI91871C (fi)
HK (1) HK1005732A1 (fi)
IE (1) IE68940B1 (fi)
NO (1) NO171639C (fi)
ZA (1) ZA895670B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
DE10019714A1 (de) 2000-04-20 2002-01-10 Gruenenthal Gmbh Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen
ES2632220T3 (es) * 2009-06-15 2017-09-11 Rigel Pharmaceuticals, Inc. Inhibidores de moléculas pequeñas de tirosina cinasa del bazo (SYK)
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
KR20140117582A (ko) * 2012-01-25 2014-10-07 바이엘 파마 악티엔게젤샤프트 치환된 페닐이미다조피라졸 및 그의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116971B (en) * 1982-03-16 1985-03-27 Erba Farmitalia Substituted 1h-pyrazolo (1 5-a) pyrimidines and process for their preparation
JPH0231374B2 (ja) * 1983-08-08 1990-07-12 Fuji Photo Film Co Ltd Harogenkaginkaraakankozairyo
GB8426447D0 (en) * 1984-10-19 1984-11-28 Kodak Ltd Photographic colour couplers
JPS6296940A (ja) * 1985-10-24 1987-05-06 Fuji Photo Film Co Ltd 熱現像感光材料

Also Published As

Publication number Publication date
DE68918651D1 (de) 1994-11-10
ATE112569T1 (de) 1994-10-15
ES2065992T3 (es) 1995-03-01
CN1040196A (zh) 1990-03-07
IE892428L (en) 1990-01-26
FI893570A (fi) 1990-01-27
FI893570A0 (fi) 1989-07-26
JPH0753730B2 (ja) 1995-06-07
DK369289A (da) 1990-01-27
CA1340444C (en) 1999-03-16
FI91871C (fi) 1994-08-25
JPH02124889A (ja) 1990-05-14
IE68940B1 (en) 1996-07-24
KR900001701A (ko) 1990-02-27
EP0353047A3 (en) 1991-07-24
FI91871B (fi) 1994-05-13
EP0353047B1 (en) 1994-10-05
DK369289D0 (da) 1989-07-26
EP0353047A2 (en) 1990-01-31
NO171639B (no) 1993-01-04
CN1034333C (zh) 1997-03-26
ZA895670B (en) 1991-03-27
CN1094049A (zh) 1994-10-26
NO893039L (no) 1990-01-29
DE68918651T2 (de) 1995-05-24
HK1005732A1 (en) 1999-01-22
KR940009785B1 (ko) 1994-10-17
NO893039D0 (no) 1989-07-26
CN1032207C (zh) 1996-07-03

Similar Documents

Publication Publication Date Title
NO173014C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO882608D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer.
NO904134D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
NO171785C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinazolinderivater
ATE194335T1 (de) 4,5-diaryloxazol-derivate
DK0770079T3 (da) Heterobicykliske derivater
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO172490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater
NO171639C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater
ATE140229T1 (de) Benzoxazepinon-verfahren
DE3862791D1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
NO894325L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO165593C (no) Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater.